Noevir Holdings Co., Ltd. AI Stock Analysis
Want to see JP:4928 full AI Analyst Report?
Noevir Holdings Co., Ltd. (4928) AI Stock Analysis
Noevir Holdings Co., Ltd.
(TSE/TYO:4928)
Noevir Holdings (JP:4928) achieves a strong overall score, primarily driven by its pristine balance sheet, expanding net income, and a highly attractive 5.10% dividend yield. While short-term technical indicators show bearish momentum and recent cash flow conversion has weakened slightly, the stock's oversold status and robust underlying fundamentals provide a solid foundation.
Noevir Holdings Co., Ltd. (4928) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 156.95B
- Dividend Yield
- 5.06%
- Average Volume (3M)
- 84.57K
- Price to Earnings (P/E)
- 19.1
- Beta (1Y)
- 0.30
- Revenue Growth
- -3.20%
- EPS Growth
- 2.32%
- Country
- Japan
- Employees
- 1,354
- Sector
- General
- Sector Strength
- 55
- Industry
- Household & Personal Products
Noevir Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
Noevir Holdings Co., Ltd. is a diversified Japanese conglomerate involved in the creation, production, and distribution of cosmetics, pharmaceuticals, and health food items. Its operations span a wide international footprint, including key markets su...
How the Company Makes Money
Noevir Holdings makes money mainly through consolidated sales generated by its operating subsidiaries’ cosmetics and personal care businesses. Revenue is primarily earned from (1) selling skincare and cosmetics products to end customers via establish...
Noevir Holdings Co., Ltd. Financial Statement Overview
Summary
Noevir Holdings exhibits robust financial health driven by an impeccable, near-debt-free balance sheet and resilient profitability, boasting 13.1% net profit margins. While recent cash flow generation has shown some volatility, steady bottom-line growth solidifies its fundamental stability.
Income Statement
82Very PositiveBalance Sheet
95Very PositiveCash Flow
68Positive| Breakdown | TTM | Sep 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.65B | 62.65B | 64.72B | 63.82B | 62.55B | 61.14B |
| Gross Profit | 42.28B | 42.28B | 43.28B | 43.16B | 42.56B | 42.09B |
| EBITDA | 19.39B | 10.48B | 11.94B | 12.44B | 12.24B | 11.57B |
| Net Income | 8.22B | 8.22B | 8.03B | 7.97B | 7.67B | 7.59B |
Balance Sheet | ||||||
| Total Assets | 75.45B | 75.45B | 76.49B | 76.47B | 77.25B | 76.78B |
| Cash, Cash Equivalents and Short-Term Investments | 25.67B | 25.67B | 26.93B | 29.22B | 28.88B | 29.75B |
| Total Debt | 664.00M | 664.00M | 742.00M | 828.00M | 914.00M | 1.00B |
| Total Liabilities | 20.82B | 20.82B | 22.28B | 22.56B | 24.04B | 24.39B |
| Stockholders Equity | 54.16B | 54.16B | 53.77B | 53.48B | 52.79B | 52.06B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 3.93B | 5.66B | 8.50B | 6.89B | 5.30B |
| Operating Cash Flow | 0 | 4.68B | 7.93B | 9.12B | 7.62B | 5.84B |
| Investing Cash Flow | 0 | 2.07B | -2.42B | 1.52B | -3.54B | -255.00M |
| Financing Cash Flow | 0 | -8.18B | -7.92B | -7.71B | -7.49B | -7.38B |
Noevir Holdings Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4928, the sentiment is Positive. The current price of 4585.00 is below the 20-day moving average (MA) of 4604.75, above the 50-day MA of 4574.53, and above the 200-day MA of 4386.70, indicating a neutral trend. The MACD of -12.79 indicates Positive momentum. The RSI at 50.97 is Neutral, neither overbought nor oversold. The STOCH value of 23.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4928.
Noevir Holdings Co., Ltd. Peers Comparison
Overall Rating
- JP:492874Outperform
JP:445272.6Outperform
JP:492771Outperform
JP:491167.8Neutral
JP:492267Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:4928 | 74Outperform | JPY 153.70B | 19.06 | ― | 5.06% | -3.20% | 2.32% |
| JP:4452 | 73Outperform | JPY 3.55T | 25.70 | 12.88% | 1.95% | 6.31% | 18.40% |
| JP:4927 | 71Outperform | JPY 314.70B | 29.38 | 6.84% | 3.56% | 1.17% | 10.12% |
| JP:4911 | 68Neutral | JPY 1.59T | 34.10 | ― | 1.23% | 5.79% | ― |
| JP:4922 | 67Neutral | JPY 324.79B | 26.31 | 4.51% | 2.38% | 4.49% | 70.29% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4928 | Noevir Holdings Co., Ltd. | 4585.00 | 282.26 | 6.56% | |
| JP:4452 | Kao Corp | 3969.00 | 718.15 | 22.09% | |
| JP:4922 | Kose Corporation | 5876.00 | 893.89 | 17.94% | |
| JP:4927 | Pola Orbis Holdings | 1461.00 | 182.17 | 14.25% | |
| JP:4911 | Shiseido Company,Limited | 4070.00 | 1457.95 | 55.82% |
Noevir Holdings Co., Ltd. Corporate Events
Noevir Approves 232-Yen Year-End Dividend
Noevir Holdings’ board approved a year-end dividend from retained earnings for the fiscal year ended September 30, 2026, with a record date of September 30, 2026, and an effective date of December 10, 2026. The dividend is 232 yen per share, compared...
Noevir Holdings Announces Proposed Changes to Representative Directors and Board Members
Noevir Holdings announced proposed changes to its representative directors, directors, Audit & Supervisory Board members, executive officers and general managers at the company and two subsidiaries. The changes include Hiroshi Okura becoming chairman...
Noevir Holdings Reports Fiscal 2026 Results as Sales and Operating Income Decline
Noevir Holdings Co., Ltd. reported consolidated results for the fiscal year ended September 30, 2026, with net sales of 62.651 billion yen, down 3.2% year on year, and operating income of 9.424 billion yen, down 14.9%; ordinary income fell 16.0% to 9...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 11, 2026